Principal Investigator
Ramon Flores Gonzalez
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20220318
Clinical Trial Summary
A MULTICENTER, SINGLE-ARM, OPEN-LABEL, EXTENSION, ROLLOVER STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Multiple Sclerosis
Contact Information
Study Contact
Yanet Babcock
Phone Number
+1 (305) 2431088
Email
ybabcock@miami.edu